dr. finn on regorafenib for the treatment for patients with hcc
Published 7 years ago • 966 plays • Length 16:35Download video MP4
Download video MP3
Similar videos
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
1:34
dr. finn on results of resource study in liver cancer
-
3:48
clinical experience with regorafenib in hcc
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
5:31
practical advice for using regorafenib
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
2:18
dr. finn on biomarkers of response in hcc
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
11:24
managing toxicities associated with regorafenib
-
8:25
key takeaway 4: second-line regorafenib after tki in hcc
-
2:11
dr. finn on the rationale for the phase iii keynote-240 trial in hcc
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
1:45
dr. finn on current and emerging agents in the field of hcc
-
5:22
impact of resorce findings on hcc clinical practice